AwardTape · Defense awards · Research and development · Health R&D · W81XWH21C0043
W81XWH21C0043: $0 definitive contract to CFD Research Corporation
CFD Research Corporation holds a definitive contract from Defense Health Agency with $0 obligated since Oct 2023 and $850K obligated over its life, against a ceiling of $850K. Latest action Oct 27, 2023.
Mrdc basic research and development DHA phase iii sbir proposal 30001, project titled, heavy weapon training blast overpressure (bop) tools for integration into range mangers toolkit (rmtk)
| PIID | W81XWH21C0043 |
|---|---|
| Type | definitive contract |
| Company | CFD Research Corporation |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $850K |
| Ceiling (base and all options) | $850K |
| Base date | Mar 15, 2021 |
| Latest action | Oct 27, 2023 |
| End date | Sep 14, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | AL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial